Imunon, Inc. — Director's Dealing 2022

Mar 3, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2022-03-02

Reporting Person: Fritz Frederick J. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-02	Celsion Corporation Common Stock	P	2000	$4.686	Acquired	6766	Direct

Footnotes

F1: The shares were purchased on the open market.